"A székesfehérvári Mentaház Magánorvosi Központ több mint 50 szakorvosa várja pácienseit 40 féle szakrendelésén. A legkorszerűbb diagnosztikai háttérrel biztosítjuk gyógyításra váró pácienseink magas szintű ellátását."

During the past decade, Mentahaz Maganorvosi Kozpont conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mentahaz Maganorvosi Kozpont" #1 sponsor was "ImmuPharma" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 1 trials sponsored, "Redwood Pharma AB" with 1 trials sponsored and "Société des Produits Nestlé (SPN)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mentahaz Maganorvosi Kozpont" #1 collaborator was "Cross Research S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mentahaz Maganorvosi Kozpont" are "Cardiovascular Disease" (2 trials), "Lupus Erythematosus, Systemic" (2 trials), "Dry Eye Syndromes" (1 trials), "Healthy Infants" (1 trials) and "Moderate to Severe Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Mentahaz Maganorvosi Kozpont" in a lesser frequency.

Most popular intervention types in "Mentahaz Maganorvosi Kozpont" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "IPP-201101" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Breast-feeding" (1 trials) and "EU-Humira" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mentahaz Maganorvosi Kozpont" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mentahaz Maganorvosi Kozpont". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mentahaz Maganorvosi Kozpont, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mentahaz Maganorvosi Kozpont, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".